Retaglutide is a novel GLP-1 receptor agonist currently under investigation for the treatment of type 2 diabetes. This medication works by mimicking the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring https://hannawqah144473.blogoxo.com/39335116/semaglutide-a-potential-solution-for-diabetes